Heterogeneous effects of tissue inhibitors of matrix metalloproteinases on cardiac fibroblasts

Keyphrases

• Cardiac Fibroblasts 100%
• Matrix Metalloproteinase Inhibitors 100%
• Tissue Inhibitor of metalloproteinase-1 (TIMP-1) 100%
• Heterogeneous Treatment Effects 100%
• Matrix Metalloproteinases 25%
• Myofibroblast 16%
• Bromodeoxyuridine 16%
• Phenotypic Differentiation 16%
• Overexpression 8%
• Adenovirus 8%
• Recombinant 8%
• Fold Increase 8%
• α-smooth muscle Actin (α-SMA) 8%
• Adenoviral 8%
• Conditioned Medium 8%
• Tissue Repair 8%
• Cardiac Remodeling 8%
• Collagen Synthesis 8%
• Fibroblast Proliferation 8%
• Pathophysiological Roles 8%
• Natural Inhibitors 8%
• Fibroblast Apoptosis 8%
• Traditional Roles 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Tissue Inhibitor of Metalloproteinase 100%
• Matrix Metalloproteinase 100%
• Infection 40%
• Matrix Metalloproteinase Inhibitor 20%
• Broxuridine 20%
• Tissue Inhibitor of Metalloproteinase 1 20%
• Adenoviridae 10%
• Tissue Repair 10%
• Recombinant 10%
• Smooth Muscle Actin 10%
• Heart Ventricle Remodeling 10%